Comparison of Three Methods for Early Detection of Breast Cancer

• Status: Enrolling by invitation
• Trial end date: 2022-06-15
• Target enrollment: 0
• Participant gender: Female

Summary

Subjects with suspicious breast lesion (BIRADS category 4/5) who are scheduled to undergo biopsy will be recruited to undergo imaging evaluation with Contrast Enhanced Dual Energy Mammography (CEDM), Contrast Enhanced Breast MR (CEMR) and Contrast Enhanced Ultrasound (CEUS).

• Phase: Early Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Mayo Clinic

Criteria

Inclusion Criteria:

• Provision of signed and dated informed consent form

• Stated willingness to comply with all study procedures and availability for the duration of the study

• Patients, greater than 30 years of age

• In good general health as evidenced by medical history

• BIRADS 4 or 5 suspicious breast lesions who are scheduled for breast biopsy.

Exclusion Criteria:

• Patients who are less than 30 years of age

• Have known or suspected cardiac shunts

• Have history of hypersensitive allergic reactions to any imaging contrast agents

• Pregnant (a urine pregnancy test will be given at no cost to the patient)

• Are nursing babies

• Poor renal function

• Are unwilling or unable (such as having a pacemaker) to undergo a CEMR